$EG
EVEREST GROUP, LTD. Stock $eg

$eg Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000109507322000011 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$242.8M	$260.4M
YoY Change	-6.75%	-86.86%
Cost Of Revenue	$1.790B
YoY Change
Gross Profit	-$1.547B
YoY Change
Gross Profit Margin	-637.14%
Selling, General & Admin	$619.2M	$501.4M
YoY Change	23.5%	9.38%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.570B	$2.355B
YoY Change	9.15%	26.06%
Operating Profit	-$4.118B
YoY Change
Interest Expense	-$160.9M	-$15.60M
YoY Change	931.65%	-305.72%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$301.8M	$373.1M
YoY Change	-19.1%	-955.29%
Income Tax	$4.095M	$31.20M
% Of Pretax Income	1.36%	8.36%
Net Earnings	$297.8M	$341.9M
YoY Change	-12.9%	1957.92%
Net Earnings / Revenue	122.62%	131.28%
Basic Earnings Per Share	$7.57	$8.53
Diluted Earnings Per Share	$7.56	$8.52
COMMON SHARES
Basic Shares Outstanding	38.82M shares	39.54M shares
Diluted Shares Outstanding	38.84M shares	39.60M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$1.778B	$1.133B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$27.52B	$2.173B
YoY Change	1166.32%	20.48%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$37.99B	$33.60B
YoY Change	13.07%	23.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$38.84M	$24.00M
YoY Change	61.85%	-86.29%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$106.5M	$175.0M
YoY Change	-39.12%	-42.05%
LONG-TERM LIABILITIES
Long-Term Debt	$3.089B	$1.911B
YoY Change	61.64%	202.37%
Other Long-Term Liabilities	$693.1M	$578.0M
YoY Change	19.91%	98.63%
Total Long-Term Liabilities	$3.782B	$2.489B
YoY Change	51.95%	169.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$106.5M	$175.0M
Total Long-Term Liabilities	$3.782B	$2.489B
Total Liabilities	$28.46B	$23.91B
YoY Change	19.01%	28.27%
SHAREHOLDERS EQUITY
Retained Earnings	$11.94B	$10.85B
YoY Change	10.04%	5.77%
Common Stock		$698.0K
YoY Change		0.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$3.646B
YoY Change		0.65%
Treasury Stock Shares		29.73M shares
Shareholders Equity	$9.528B	$9.683B
YoY Change
Total Liabilities & Shareholders Equity	$37.99B	$33.60B
YoY Change	13.07%	23.41%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	$297.8M	$341.9M
YoY Change	-12.9%	1957.92%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$846.4M	$904.4M
YoY Change	-6.41%	78.73%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$421.3M	-$455.5M
YoY Change	-7.5%	76.41%
Cash From Investing Activities	-$421.3M	-$455.5M
YoY Change	-7.51%	76.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.322M	$23.55M
YoY Change	-94.39%	-88.23%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$93.56M	-$108.9M
YoY Change	-14.06%	-54.84%
NET CHANGE
Cash From Operating Activities	$846.4M	$904.4M
Cash From Investing Activities	-$421.3M	-$455.5M
Cash From Financing Activities	-$93.56M	-$108.9M
Net Change In Cash	$337.4M	$331.0M
YoY Change	1.92%	3351.61%
FREE CASH FLOW
Cash From Operating Activities	$846.4M	$904.4M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q1	re	Assumed Losses And Loss Adjustment Expenses AssumedLossesAndLossAdjustmentExpenses		USD
CY2022Q1	re	Contractual Commitments Investment Period Expiration Date ContractualCommitmentsInvestmentPeriodExpirationDate	2026-12-31
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Seon Place – 4th Floor
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001095073
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease		USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal		USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease		USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal		USD
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	1-15731
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	EVEREST RE GROUP, LTD.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0365432
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	141 Front Street
CY2022Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	PO Box HM 845
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Hamilton
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	HM 19
CY2022Q1	dei	Entity Address Country EntityAddressCountry	BM
CY2022Q1	dei	City Area Code CityAreaCode	441
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	295-0006
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Security12b Title Security12bTitle	Common Shares, $0.01 par value
CY2022Q1	dei	Trading Symbol TradingSymbol	RE
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39437963	shares
CY2022Q1	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	21998415000	USD
CY2021Q4	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	22308272000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	22693029000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	41591000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	29738000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1780526000	USD
CY2021Q4	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	3293598000	USD
CY2021Q4	us-gaap	Funds Held Under Reinsurance Agreements Asset FundsHeldUnderReinsuranceAgreementsAsset	868601000	USD
CY2021Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	2381000	USD
CY2021Q4	us-gaap	Assets Assets	38185283000	USD
CY2022Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	19495637000	USD
CY2021Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	19009486000	USD
CY2021Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	35669000	USD
CY2021Q4	us-gaap	Unearned Premiums UnearnedPremiums	4609634000	USD
CY2021Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	18391000	USD
CY2021Q4	us-gaap	Reinsurance Payable ReinsurancePayable	449723000	USD
CY2022Q1	re	Loss In Course Of Payment LossInCourseOfPayment	133888000	USD
CY2021Q4	re	Loss In Course Of Payment LossInCourseOfPayment	260684000	USD
CY2022Q1	us-gaap	Senior Notes SeniorNotes	2346147000	USD
CY2021Q4	us-gaap	Senior Notes SeniorNotes	2345800000	USD
CY2021Q4	us-gaap	Subordinated Debt SubordinatedDebt	223774000	USD
CY2022Q1	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	519000000	USD
CY2021Q4	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	519000000	USD
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	17348000	USD
CY2021Q4	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	16698000	USD
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	539896000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	28046103000	USD
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69790000	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	698000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2274431000	USD
CY2021	re	Accumulated Other Comprehensive Income Loss Tax AccumulatedOtherComprehensiveIncomeLossTax	26781000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	11523000	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	30524000	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3847308000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11936489000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11699836000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	9527629000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10139180000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37986782000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	38185283000	USD
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	242830000	USD
CY2021Q1	us-gaap	Net Investment Income NetInvestmentIncome	260413000	USD
CY2022Q1	us-gaap	Debt Securities Held To Maturity Credit Loss Expense Reversal DebtSecuritiesHeldToMaturityCreditLossExpenseReversal	11853000	USD
CY2021Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	29056000	USD
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-4914000	USD
CY2021Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	16823000	USD
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-153627000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	38902000	USD
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	15363000	USD
CY2021Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	56593000	USD
CY2022Q1	re	Corporate Expenses CorporateExpenses	14020000	USD
CY2021Q1	re	Corporate Expenses CorporateExpenses	12378000	USD
CY2022Q1	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	24078000	USD
CY2021Q1	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	15639000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	301847000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	373095000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	297751000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	341862000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-810999000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-292281000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-844343000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-299820000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.57
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	8.53
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.56
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	8.52
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.55
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.55
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	9527629000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	9682882000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	297751000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	341862000	USD
CY2022Q1	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	14203000	USD
CY2021Q1	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	105460000	USD
CY2022Q1	re	Payments For Shares Issued For Share Based Compensation Net Of Expense PaymentsForSharesIssuedForShareBasedCompensationNetOfExpense	14450000	USD
CY2021Q1	re	Payments For Shares Issued For Share Based Compensation Net Of Expense PaymentsForSharesIssuedForShareBasedCompensationNetOfExpense	10583000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1322000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	23545000	USD
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	61097000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	62229000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	16692000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	12507000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-93561000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-108864000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5807000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-8972000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	337357000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	331009000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1440861000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	801651000	USD
CY2022Q1	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	67033000	USD
CY2021Q1	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	25584000	USD
CY2022Q1	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	125881000	USD
CY2021Q1	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	14518000	USD
CY2022Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1251000	USD
CY2021Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-24908000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Reinsurance Premiums IncreaseDecreaseInPrepaidReinsurancePremiums	7167000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Reinsurance Premiums IncreaseDecreaseInPrepaidReinsurancePremiums	27071000	USD
CY2022Q1	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	632398000	USD
CY2021Q1	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	655070000	USD
CY2022Q1	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-1146000	USD
CY2021Q1	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-162000	USD
CY2022Q1	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	4045000	USD
CY2021Q1	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	196631000	USD
CY2022Q1	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	46310000	USD
CY2021Q1	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	105390000	USD
CY2022Q1	re	Increase Decrease In Losses In Course Of Payment IncreaseDecreaseInLossesInCourseOfPayment	-125074000	USD
CY2021Q1	re	Increase Decrease In Losses In Course Of Payment IncreaseDecreaseInLossesInCourseOfPayment	11980000	USD
CY2022Q1	re	Change In Equity Adjustments In Limited Partnerships ChangeInEquityAdjustmentsInLimitedPartnerships	97831000	USD
CY2021Q1	re	Change In Equity Adjustments In Limited Partnerships ChangeInEquityAdjustmentsInLimitedPartnerships	116767000	USD
CY2022Q1	us-gaap	Reimbursement From Limited Partnership Investment ReimbursementFromLimitedPartnershipInvestment	71174000	USD
CY2021Q1	us-gaap	Reimbursement From Limited Partnership Investment ReimbursementFromLimitedPartnershipInvestment	18125000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-47052000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	149480000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11912000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11021000	USD
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	19254000	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	17323000	USD
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-153627000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	38902000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	846439000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	904366000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	818352000	USD
CY2022Q1	re	Proceeds From Sale Of Available For Sale Securities Debt Market Value ProceedsFromSaleOfAvailableForSaleSecuritiesDebtMarketValue	418988000	USD
CY2021Q1	re	Proceeds From Sale Of Available For Sale Securities Debt Market Value ProceedsFromSaleOfAvailableForSaleSecuritiesDebtMarketValue	228278000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	90101000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	281313000	USD
CY2021Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	52211000	USD
CY2022Q1	re	Payments To Acquire Available For Sale Securities Debt Market Value PaymentsToAcquireAvailableForSaleSecuritiesDebtMarketValue	2010859000	USD
CY2021Q1	re	Payments To Acquire Available For Sale Securities Debt Market Value PaymentsToAcquireAvailableForSaleSecuritiesDebtMarketValue	1776730000	USD
CY2022Q1	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	195026000	USD
CY2021Q1	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	174981000	USD
CY2021Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	98939000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-308585000	USD
CY2021Q1	re	Net Change In Unsettled Securities Transactions NetChangeInUnsettledSecuritiesTransactions	93610000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-455521000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1778218000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1132660000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6417000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	2210000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1880000	USD
CY2022Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-weight: bold; font-size: 10.00pt">1. GENERAL</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">Everest Re Group, Ltd. (“Group”), a Bermuda company, through its subsidiaries, principally provides reinsurance and insurance in the U.S., Bermuda and international markets. As used in this document, “Company” means Group and its subsidiaries.</span></p>
CY2022Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-weight: bold; font-size: 10.00pt">2. BASIS OF PRESENTATION</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">The unaudited consolidated financial statements of the Company as of March 31, 2022 and December 31, 2021 and for the three months ended March 31, 2022 and 2021 include all adjustments, consisting of normal recurring accruals, which, in the opinion of management, are necessary for a fair statement of the results on an interim basis. Certain financial information, which is normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), has been omitted since it is not required for interim reporting purposes. The December 31, 2021 consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The results for the three months ended March 31, 2022 and 2021 are not necessarily indicative of the results for a full year. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the years ended December 31, 2021, 2020 and 2019, included in the Company’s most recent Form 10-K filing.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">The Company consolidates the results of operations and financial position of all voting interest entities ("VOE") in which the Company has a controlling financial interest and all variable interest entities ("VIE") in which the Company is considered to be the primary beneficiary. The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the facts and circumstances surrounding each entity. </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities (and disclosure of contingent assets and liabilities) at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Ultimate actual results could differ, possibly materially, from those estimates. </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">All intercompany accounts and transactions have been eliminated. </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">Certain reclassifications and format changes have been made to prior years’ amounts to conform to the 2022 presentation.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt; text-decoration: underline">Application of Recently Issued Accounting Standard Changes. </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">The Company did not adopt any new accounting standards that had a material impact during the three months ended March 31, 2022. The Company assessed the adoption impacts of recently issued accounting standards by the Financial Accounting Standards Board on the Company’s consolidated financial statements as well as material updates to previous assessments, if any, from the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. There were no new material accounting standards issued in the three months ended March 31, 2022, that impacted Group.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">Any issued guidance and pronouncements, other than those directly referenced above, are deemed by the Company to be either not applicable or immaterial to its financial statements.</span></p>
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	22693029000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	22693029000	USD
CY2022Q1	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	21998415000	USD
CY2021Q4	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	22308272000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-322708000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-40427000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-810999000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-292281000	USD
CY2021Q1	re	Gross Investment Income Before Adjustment GrossInvestmentIncomeBeforeAdjustment	266286000	USD
CY2021Q1	re	Funds Held Interest Income Expense FundsHeldInterestIncomeExpense	7966000	USD
CY2021Q1	re	Future Policy Benefit Reserve Income Expense FuturePolicyBenefitReserveIncomeExpense	-291000	USD
CY2021Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	273961000	USD
CY2021Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	13548000	USD
CY2021Q1	us-gaap	Investment Income Net InvestmentIncomeNet	260413000	USD
CY2022Q1	re	Additional Contractual Commitments AdditionalContractualCommitments	2500000000	USD
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-153627000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	38902000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	29738000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	13113000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	-1260000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	41591000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	1745000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	7298000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	-320000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	8723000	USD
CY2021Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	19009486000	USD
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	16322143000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1946365000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1843691000	USD
CY2021Q4	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	17063121000	USD
CY2020Q4	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	14478452000	USD
CY2022Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	1790798000	USD
CY2021Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	1713253000	USD
CY2022Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-935000	USD
CY2021Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-1834000	USD
CY2022Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	1789863000	USD
CY2021Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	1711419000	USD
CY2022Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	307661000	USD
CY2021Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	215302000	USD
CY2022Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	918834000	USD
CY2021Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	837035000	USD
CY2022Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	1226495000	USD
CY2021Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	1052337000	USD
CY2022Q1	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	-121934000	USD
CY2021Q1	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	-5841000	USD
CY2022Q1	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	17504555000	USD
CY2021Q1	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	15131694000	USD
CY2022Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1991082000	USD
CY2021Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1882112000	USD
CY2022Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	19495637000	USD
CY2021Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	17013806000	USD
CY2022Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	1800000000	USD
CY2021Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	1700000000	USD
CY2022Q1	re	Public Equity Portfolio Fair Value Disclosure PublicEquityPortfolioFairValueDisclosure	1400000000	USD
CY2021Q4	re	Public Equity Portfolio Fair Value Disclosure PublicEquityPortfolioFairValueDisclosure	1300000000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1780526000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	297751000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	341862000	USD
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	61097000	USD
CY2022Q1	us-gaap	Undistributed Earnings UndistributedEarnings	236653000	USD
CY2022Q1	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2021Q1	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	233504000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	276031000	USD
CY2022Q1	re	Dividend Declared Common Shareholders DividendDeclaredCommonShareholders	60282000	USD
CY2021Q1	re	Dividend Declared Common Shareholders DividendDeclaredCommonShareholders	61415000	USD
CY2022Q1	re	Numerator For Basic And Diluted Earnings Per Common Share NumeratorForBasicAndDilutedEarningsPerCommonShare	293785000	USD
CY2021Q1	re	Numerator For Basic And Diluted Earnings Per Common Share NumeratorForBasicAndDilutedEarningsPerCommonShare	337446000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	38823000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	39543000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	14000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	54000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38837000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39597000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.57
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	8.53
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.56
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	8.52
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38823000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39543000	shares
CY2022Q1	re	Basic Weighted Average Common Shares Outstanding And Nonvested Common Shares Expected To Vest BasicWeightedAverageCommonSharesOutstandingAndNonvestedCommonSharesExpectedToVest	39347000	shares
CY2021Q1	re	Basic Weighted Average Common Shares Outstanding And Nonvested Common Shares Expected To Vest BasicWeightedAverageCommonSharesOutstandingAndNonvestedCommonSharesExpectedToVest	40059000	shares
CY2022Q1	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2021Q1	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-961050000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-116707000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-844343000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-339110000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-39290000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-299820000	USD
CY2022Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1200000	USD
CY2022Q1	re	Line Of Credit Facility Uncommited Amount Available LineOfCreditFacilityUncommitedAmountAvailable	340000000.0	USD
CY2022Q1	re	Federal Home Loan Bank Advances General Debt Obligations Disclosures Maximum Percentage Of Admitted Assets Allowed For Borrowing Base FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumPercentageOfAdmittedAssetsAllowedForBorrowingBase	0.10	pure
CY2022Q1	us-gaap	Security Deposit SecurityDeposit	1800000	USD
CY2021Q1	us-gaap	Ceded Premiums Written CededPremiumsWritten	99110000	USD
CY2021Q1	re	Ceded Earned Premiums CededEarnedPremiums	78107000	USD
CY2021Q1	re	Ceded Losses And Loss Adjustment Expenses CededLossesAndLossAdjustmentExpenses	80843000	USD
CY2021Q1	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	2476000	USD
CY2021Q1	re	Assumed Earned Premiums AssumedEarnedPremiums	2476000	USD
CY2022Q1	us-gaap	Reinsurance Recoverables Gross ReinsuranceRecoverablesGross	192500000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables Gross ReinsuranceRecoverablesGross	206100000	USD
CY2022Q1	re	Reinsurance Deferred Gain Liability ReinsuranceDeferredGainLiability	14400000	USD
CY2021Q4	re	Reinsurance Deferred Gain Liability ReinsuranceDeferredGainLiability	15500000	USD
CY2022Q1	us-gaap	Debt Instrument Redemption Period End Date DebtInstrumentRedemptionPeriodEndDate	2047-05-01
CY2022Q1	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	1530000	USD
CY2021Q1	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	1462000	USD
CY2022Q1	us-gaap	Premiums Written Gross PremiumsWrittenGross	3186351000	USD
CY2021Q1	us-gaap	Premiums Written Gross PremiumsWrittenGross	2931433000	USD
CY2022Q1	us-gaap	Premiums Written Net PremiumsWrittenNet	2812013000	USD
CY2021Q1	us-gaap	Premiums Written Net PremiumsWrittenNet	2553937000	USD
CY2022Q1	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	235379000	USD
CY2021Q1	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	45204000	USD
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	242830000	USD
CY2021Q1	us-gaap	Net Investment Income NetInvestmentIncome	260413000	USD
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-153627000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	38902000	USD
CY2022Q1	re	Corporate Expenses CorporateExpenses	14020000	USD
CY2021Q1	re	Corporate Expenses CorporateExpenses	12378000	USD
CY2022Q1	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	24078000	USD
CY2021Q1	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	15639000	USD
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	15363000	USD
CY2021Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	56593000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	301847000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	373095000	USD
CY2022Q1	re	Percentage Threshold Of Company Revenue Not Exceeded By Any Other Country PercentageThresholdOfCompanyRevenueNotExceededByAnyOtherCountry	0.05	pure

Files In Submission

Name	View Source	Status
0001095073-22-000011-index-headers.html	Edgar Link	pending
0001095073-22-000011-index.html	Edgar Link	pending
0001095073-22-000011.txt	Edgar Link	pending
0001095073-22-000011-xbrl.zip	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
re-20220331.htm	Edgar Link	pending
re-20220331.xsd	Edgar Link	pending
re-20220331_cal.xml	Edgar Link	unprocessable
re-20220331_def.xml	Edgar Link	unprocessable
re-20220331_htm.xml	Edgar Link	completed
re-20220331_lab.xml	Edgar Link	unprocessable
re-20220331_pre.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EG
EVEREST GROUP, LTD. Stock $eg

2022 Q1 Form 10-Q Financial Statement

#000109507322000011 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EG EVEREST GROUP, LTD. Stock $eg

2022 Q1 Form 10-Q Financial Statement

#000109507322000011 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EG
EVEREST GROUP, LTD. Stock $eg